Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bacille calmette-guerin (1 trial)
mitumomab (1 trial)
bortezomib (velcade) (1 trial)
Carcinoma, Small Cell (Phase 3)
Lung Neoplasms (Phase 3)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Trials (2 total)
Trial APIs (3 total)